Joyce Lee

Associate Professor

University of Colorado School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Joyce Lee is an Associate Professor at the University of Colorado School of Medicine in the United States. Her research focuses on the clinical outcomes and prognostic factors in idiopathic pulmonary fibrosis and interstitial lung disease. Recent publications include studies on the effects of antifibrotic therapies, patient-centered outcomes, and molecular markers related to lung fibrosis.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Sonye K. Danoff

Associate Professor of Medicine

Johns Hopkins University School of Medicine

UNITED STATES

View details

Anne-Marie Russell

Senior Lecturer

University of Exeter

UNITED KINGDOM

View details

Scott Matson

Assistant Professor

University of Kansas Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joyce Lee

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Gazing into the Proteomic Crystal Ball: Predicting Survival in Idiopathic Pulmonary Fibrosis

Effect of Antifibrotic Use on Mortality in Patients with Idiopathic Pulmonary Fibrosis

Real-World Clinical Outcomes Based on Body Mass Index and Annualized Weight Change in Patients with Idiopathic Pulmonary Fibrosis

Differences in Patient Outcomes across the Pulmonary Fibrosis Foundation Care Center Network

FocuSSced on the Target in Systemic Sclerosis–Interstitial Lung Disease: Another Arrow in the Quiver?

Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement

Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis.

Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis

Molecular Markers of Telomere Dysfunction and Senescence are Common Findings in the Usual Interstitial Pneumonia Pattern of Lung Fibrosis.

Molecular markers of telomere dysfunction and senescence are common findings in the usual interstitial pneumonia pattern of lung fibrosis

Management of Connective Tissue Disease-Associated Interstitial Lung Disease

Idiopathic pulmonary fibrosis: Disease mechanisms and drug development

Collaborators (3)

Sonye K. Danoff

Anne-Marie Russell

Scott Matson

Make your next move.